Pharmaceutical group
A group of 5 companies with 12 medicines in 5 countries.
5 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| FOCINVEZ150mg base/50ml (eq 3mg base/ml) ยท Solution | Aprepitant | United States | Marketed | 2023 |
| IMIPENEM/CILASTATINA STERISCIENCE 500 MG/500 MG POLVO PARA SOLUCION PARA PERFUSION EFG530,1 mg + 530,7 mg ยท Polvo para soluciรณn para perfusiรณn | Imipenem, Cilastatin | Spain | Authorised | 2024 |
| Meropenem Steriscience 1000 mg, poeder voor oplossing voor injectie of infusiePoeder voor oplossing voor injectie of infusie | Meropenem | Netherlands | Authorised | 2022 |
| Meropenem Steriscience 1000 mg praลกak za otopinu za injekciju/infuzijuPraลกak za otopinu za injekciju / infuziju | Meropenem | Croatia | Not marketed | 2022 |
| MEROPENEM STERISCIENCE 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION2273, 20 mg ยท Polvo para soluciรณn inyectable y para perfusiรณn | Meropenem | Spain | Authorised | 2025 |
| Meropenem Steriscience 500 mg, poeder voor oplossing voor injectie of infusiePoeder voor oplossing voor injectie of infusie | Meropenem | Netherlands | Authorised | 2022 |
| Meropenem Steriscience 500 mg praลกak za otopinu za injekciju/infuzijuPraลกak za otopinu za injekciju / infuziju | Meropenem | Croatia | Authorised | 2022 |
| METHYLENE BLUE100mg/10ml (10mg/ml) | 10mg/2ml (5mg/ml) | 50mg/10ml (5mg/ml) | 5mg/ml (5mg/ml) ยท Solution | Methylthioninium chloride | United States | Marketed | 2023 |
| VANCOCIN HYDROCHLORIDE10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1GM BASE/VIAL | 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG BASE/VIAL | 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn f ยท Injectable | Vancomycin | United States | Not marketed | 1964 |
| ZIPRASIDONE MESYLATE20mg base/vial ยท Powder | Ziprasidone | United States | Marketed | 2019 |
| SYNTOCINON 5 IU injection | Oxytocin | Saudi Arabia | Authorised | |
| SELENIOUS ACID600mcg/10ml ยท Injection | Selenious acid | United States | tentative | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 | 4 | 1 | CompaniesAll medicines |
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
| Croatia | 2 | 2 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Report an error or request removalCorrections from the company itself are welcome.
Keep Steriscienceโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callLicence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Well-known pharmaceutical groups, each with all its companies.
